Collegium Pharmaceutical
Collegium Pharmaceutical, based in Stoughton, MA, develops and markets medications for serious medical conditions and is actively involved in community and environmental health initiatives.
Services
Collegium Pharmaceutical offers a range of services aimed at improving the health and well-being of those with serious medical conditions. The company provides educational resources and support for healthcare professionals treating complex medical issues. Additionally, it engages in multiple initiatives to support community and environmental health through its environmental, social, and governance programs.
Products
Collegium Pharmaceutical's product portfolio includes five key medications: Xtampza ER, Belbuca, Nucynta ER, Nucynta IR, and Symproic. These medications are designed to offer differentiated solutions for patients dealing with various serious medical conditions. Each product aims to provide effective treatment while also emphasizing safety and responsible usage.
Company History
Located at 100 Technology Center Drive, Suite 300, Stoughton, MA 02072, Collegium Pharmaceutical has established itself as a dedicated player in the pharmaceutical sector. The company is committed to improving the lives of people with serious medical conditions through its specialized medications and community-focused initiatives. Their efforts are focused on advancing healthcare and supporting community health and well-being.
Community and Educational Initiatives
Part of Collegium Pharmaceutical's mission involves engaging with the community through various educational and support programs. The company offers a scholarship program for Massachusetts-based high school seniors pursuing STEM-related majors. Additionally, it partners with organizations such as Life Science Cares, MassBioEd, Kids in Tech, and Science from Scientists to support STEM education. These initiatives aim to bolster science and technology learning among young students.